US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Biofrontera AG (B8FK) 銘柄情報

Biofrontera AG (B8FK)

2.31

0.00

(0.00%)

終了 6月25日 5:00AM

Biofrontera AG (B8FK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

2.31

( - )

買値

2.22

売値

2.39

出来高

19

2.26 日の範囲 2.39

0.00 52 週間の範囲 0.00

時価総額

前日終値

2.31

始値

2.39

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,504 €

発行済株式数

6,076,862

配当利回り

PER

-2.14

1 株当たり利益 (EPS)

-0.4

歳入

13.63M

純利益

-2.44M

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the tr... Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. In addition, the company focus on photodynamic therapy (PDT) for the treatment of actinic keratosis and keratinocyte skin cancers, including basal cell carcinoma. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.biofrontera.com

本社

Leverkusen, Germany

設立

1997

Biofrontera AG is listed in the Healthcare sector of the Tradegate (DE) with ticker B8FK. The last closing price for Biofrontera was 2.31 €. Over the last year, Biofrontera shares have traded in a share price range of 0.00 € to 0.00 €.

Biofrontera currently has 6,076,862 shares in issue. The market capitalisation of Biofrontera is 14.04 € million. Biofrontera has a price to earnings ratio (PE ratio) of -2.14.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

B8FK - Frequently Asked Questions (FAQ)

What is the current Biofrontera AG share price?

The current share price of Biofrontera AG is 2.31 €

How many Biofrontera AG shares are in issue?

Biofrontera AG has 6,076,862 shares in issue

What is the market cap of Biofrontera AG?

The market capitalisation of Biofrontera AG is EUR 14.04M

What is the 1 year trading range for Biofrontera AG share price?

Biofrontera AG has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Biofrontera AG?

The price to earnings ratio of Biofrontera AG is -2.14

What is the cash to sales ratio of Biofrontera AG?

The cash to sales ratio of Biofrontera AG is 1.05

What is the registered address of Biofrontera AG?

The registered address for Biofrontera AG is Hemmelrather Weg 201, Leverkusen, North Rhine-Westphalia, 51377

What is the Biofrontera AG website address?

The website address for Biofrontera AG is www.biofrontera.com

Which industry sector does Biofrontera AG operate in?

Biofrontera AG operates in the Pharmaceuticals sector

MightyX

MightyX 9分前

Nearly hit .24 at roughly +25%

don estaban

don estaban 9分前

Got filled today on the bid will be in the bid tomorow as well

Eli's Gone

Eli's Gone 10分前

6 errors on the IF---brutal

madcasper

madcasper 17分前

saw this one on the most posted board yesterday and was keeping an eye on it.
nice day traders congratulations here :)
GNIS

rogers711

rogers711 19分前

It’s an early feasibility, probably still won’t get approved.

rogers711

rogers711 20分前

SSKILLZ1

SSKILLZ1 21分前

I thought I have been watching lousy baseball all season apparently I was wrong, the 2nd game of the DH they committed 6 errors and I think the scorer could of given them 1 or two more to be honest. Glad the brilliant gm focused on defense in the offseason I don't think I seen a team play a sloppier

wadirum1

wadirum1 24分前

STRC is tempting down here. But MSTR is by far the better investment. If bitcoin keeps dropping, both stocks are doomed. If bitcoin bounces here, MSTR goes to the moon.

cancerfreed

cancerfreed 25分前

I’m glad people are realizing SPCX stock has nothing going for other than a big hype. People bought and sold them to buy RDW stock which has much more business going well. Time to buy rdw at its lowest price now

wolfknock

wolfknock 27分前

Yes, so began your crusade of protecting all of the ignorant CYDY shareholders. We can never thank you enough for the thousands of wasted hours you have dedicated to the education of the CYDY shareholders. Keep up the good work!

Miamifl

Miamifl 30分前

It just pays for me to wait and see what our own CEO has to say when she is ready.

DrivenByPain

DrivenByPain 31分前

🤑SNTX🤑 Let's Take A Blast To The Moon Baby🤑

https://www.youtube.com/watch?v=U7LZnMM268E

Truthsocial

Truthsocial 32分前

You're lost in the shuffle tell us what you don't mean lol...and the other shenanigans....which one is skat???

Let's go ISOPET now and RDGL soon.. imo

Miamifl

Miamifl 32分前

Hey Gimmee, In response to your question, this was an example of what I’m referring to: The Post credit belongs to SPEAKHIM. He said the following: “ Unless Kelly tells us that this is happening with Ken going over to bioelectronics corporation, which I personally highly doubt... , The flood o

MightyX

MightyX 33分前

Reaching the 20% overnight limit

cancerfreed

cancerfreed 34分前

My Mexican doctor bought 1K shares at ipo price $135 and sold them at $200. Many of them like him want to make quick buck. Many more are selling fast before price drops below $135

LJ-Bodhi

LJ-Bodhi 34分前

NRX promptly disclosed potential red flags with Kadima in the August 2025 quarterly report (first quarterly report after the deal was announced), and the concerns were based on questions about Kadima's representations and warranties:

As of the date of this Report, the transactions con

MrMontag

MrMontag 36分前

You keep assuming it will be built and in full production. 🤔 Maybe we will find out "in a few weeks". 🤔🤣

MnymanJ

MnymanJ 40分前

I plan to see how it evolves.

justus1

justus1 49分前

Here's your buddy! I'm working the night shift for 100lb. lol

The Billion-Dollar Memory Patent Battle: Why Micron’s Fight With Netlist (NLST) Could Reshape the AI Memory Industry
Gary Wallach
Jun 24

easymonee

easymonee 51分前

Your post....Your going to have to post this statement from Marshall as I have not seen it. Marshall posted in early 2026 that Kaplan sold 2 Billion MDCE shares, and had less than 100M remaining.
Yet 1.249 Billion shares that Kaplan acquired in 2025 Kaplan sold in Q3, the Q3 shows. That shows

G_rokk

G_rokk 51分前

ya ok the sell off continues right before the most important decision
hope i’m wrong but this doesn’t favor an approval

pdicamillo1

pdicamillo1 51分前

2 insider buys from yesterday. Wayne bought 1,300 shares $2.50 and Michael Kornelsen bought 100 shares $2.50. Hopefully more to come. I would love to see one of the engineers also join the party. Show us investors that they believe in the tech and know the stock is currently undervalued.

Naught

Naught 53分前

100% Ron
Gemini must be consistent.. no doubling back on itself with supposedly new findings all the time lately. The original script seemed plausible.

Zinc One Resources

Nippon Seiki (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。